These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 36873956)

  • 1. A Case of Castleman's Disease during the Long-Term Course of Membranous Nephropathy.
    Nakajima S; Nagai K; Sakata A; Usui J; Yamagata K; Ueda A
    Case Rep Nephrol; 2023; 2023():4926000. PubMed ID: 36873956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membranous nephropathy associated with multicentric Castleman's disease that was successfully treated with tocilizumab: a case report and review of the literature.
    Saiki R; Katayama K; Hirabayashi Y; Oda K; Fujimoto M; Murata T; Nakajima A; Dohi K
    BMC Nephrol; 2021 Jun; 22(1):216. PubMed ID: 34107915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case of Castleman's Disease with a Marked Infiltration of IgG4-Positive Cells in the Renal Interstitium.
    Sawada E; Shioda Y; Ogawa K; Iwashita T; Ono Y; Hasegawa H; Maeshima A
    Diagnostics (Basel); 2024 Feb; 14(5):. PubMed ID: 38472948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 receptor inhibition with tocilizumab in various renal involvements associated with multicentric Castleman's disease: a report of three cases.
    Komaba H; Nakazawa T; Yamaguchi Y; Kumagai S; Fukagawa M
    NDT Plus; 2008 Dec; 1(6):423-426. PubMed ID: 28656995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
    Seida A; Wada J; Morita Y; Baba M; Eguchi J; Nishimoto N; Okino T; Ichimura K; Yoshino T; Makino H
    Am J Kidney Dis; 2004 Jan; 43(1):E3-9. PubMed ID: 14712466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of mesangial proliferative glomerulonephritis complicated with multicentric Castleman's disease].
    Fujiwara H; Mise N; Ishimoto Y; Kotera N; Tanaka M; Tanaka S; Kurita N; Fujii A; Yamaguchi Y; Sugimoto T
    Nihon Jinzo Gakkai Shi; 2011; 53(2):189-94. PubMed ID: 21516705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.
    Nagai K; Usui J; Noguchi K; Unai K; Hiwatashi A; Arakawa Y; Togashi A; Morito N; Saito C; Yoh K; Tsuruoka S; Kojima H; Aita K; Nagata M; Yamagata K
    Pathol Int; 2011 Nov; 61(11):686-90. PubMed ID: 22029682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.
    Maeshima A; Nakasatomi M; Henmi D; Yamashita S; Kaneko Y; Kuroiwa T; Hiromura K; Nojima Y
    CEN Case Rep; 2012 May; 1(1):7-11. PubMed ID: 28509146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
    Lajoie G; Kumar S; Min KW; Silva FG
    Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentric Castleman's disease with renal amyloidosis and mesangial proliferative glomerulonephritis: a case report.
    Tan Z; Wang L; Wang C; Gao L; Yang Y
    Int J Clin Exp Med; 2015; 8(2):2966-73. PubMed ID: 25932265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome.
    Casey D; Romero K; Patel R; Ouellette T; Anasseri S; Eftekhari P
    Cureus; 2022 Oct; 14(10):e30032. PubMed ID: 36348912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report on mesangial proliferative glomerulonephritis with multicentric Castleman's disease: Approach to the onset mechanism of immunoglobulin A nephropathy.
    Karasawa K; Ogura S; Miyabe Y; Akiyama K; Nitta K; Moriyama T
    Clin Immunol; 2020 Mar; 212():108347. PubMed ID: 31978558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A patient with Castleman's disease initially manifesting symmetrical synovitis with pitting oedema.
    Kondo J; Arinuma Y; Matsueda Y; Hasegawa Y; Muramatsu T; Kanayama Y; Hoshiyama T; Tono T; Tanaka S; Oku K; Yamaoka K
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):309-313. PubMed ID: 35092673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a Caucasian case of multifocal Castleman's disease with TAFRO syndrome with a pathophysiology targeted therapy - a case report.
    Tedesco S; Postacchini L; Manfredi L; Goteri G; Luchetti MM; Festa A; Gabrielli A; Pomponio G
    Exp Hematol Oncol; 2015; 4(1):3. PubMed ID: 25671135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of multicentric Castleman's disease with pulmonary involvement].
    Morise M; Shimomoto H; Honda T; Mori Y
    Nihon Kokyuki Gakkai Zasshi; 2003 Jan; 41(1):59-65. PubMed ID: 12693008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of nephrotic syndrome after removal of localized Castleman's disease.
    Keven K; Nergizoğlu G; Ateş K; Erekul S; Orhan D; Ertürk S; Tulunay O; Karatan O; Ertuğ AE
    Am J Kidney Dis; 2000 Jun; 35(6):1207-11. PubMed ID: 10845836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab-effective multicentric Castleman's disease with infiltration of eosinophil and IgG
    Katsumata Y; Ikari J; Tanaka N; Abe M; Tsushima K; Yonemori Y; Tatsumi K
    Respir Med Case Rep; 2018; 25():25-29. PubMed ID: 29998054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease.
    Takeuchi M; Sato Y; Takata K; Kobayashi K; Ohno K; Iwaki N; Orita Y; Yoshino T
    Pathol Res Pract; 2012 Dec; 208(12):746-9. PubMed ID: 23102767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Castleman's disease and glomerular nephropathy (apropos of 1 case].
    Combe C; Bouchet JL; Potaux L; Morel D; Deminière C; Coindre JM; Aparicio M
    Nephrologie; 1989; 10(3):163-6. PubMed ID: 2691915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral Renal Vein Thrombosis and Chylous Ascites in Phospholipase A2 Receptor-Associated Membranous Nephropathy: A Case Report.
    Shiraishi K; Chesta F; Nishimura Y; Chong CM
    Cureus; 2024 Jun; 16(6):e63434. PubMed ID: 39077230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.